$0.48
arrow_drop_down3.98%Key Stats | |
---|---|
Open | $0.50 |
Prev. Close | $0.49 |
EPS | - |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $279.11M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 0.48 | 0.50 |
52 Week Range | 0.14 | 0.60 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | - |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment Proposal
Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.
TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business Combination
TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business Combination